Antiproliferative and apoptotic effects of iron chelators on human cervical carcinoma cells

Gynecologic Oncology

Volumn 85, Issue 1, 2002, Pages 95-102

  Simonart, Thierry ^a   Boelaert, Johan R ^b   Mosselmans, Roger ^c   Andrei, Graciela ^d   Noel, Jean Christophe ^a   De Clercq, Erik ^d   Snoeck, Robert ^d  

^a ERASME HOSPITAL   (Belgium)

^b General Hospital St Jan   (Belgium)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Apoptosis; Cervical carcinoma; Deferiprone; Desferrioxamine (DFO); Proliferating cell nuclear antigen (PCNA)

Indexed keywords

CHELATING AGENT; CYCLINE; DEFERIPRONE; DEFEROXAMINE; FERROUS CHLORIDE; THYMIDINE; TRITIUM;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HELA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IRON CHELATION; NONHUMAN; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; WART VIRUS;

EID: 0036222988     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6570     Document Type: Article

References (37)

1. Human papillomavirus in pathogenesis of anogenital cancer
2. Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia
3. Prevention of cervix cancer
4. Chemotherapy as a palliative treatment in carcinoma of the uterine cervix
5. High dose rate brachytherapy in the treatment of cervical carcinoma
6. Iron withholding: A defense against viral infections
7. Altered iron metabolism in HIV infection: Mechanisms, possible consequences, and proposals for management
8. Inhibition of human immunodeficiency virus type 1 replication in human mononuclear blood cells by the iron chelators deferoxamine, deferiprone and bleomycin
9. Iron in cancer
10. The role of iron in cancer
11. Induction of apoptosis by iron deprivation in human leukemic CCRF-CEM cells
12. Iron deprivation-induced apoptosis in HL-60 cells
13. Deferoxamine inhibition of human neuroblastoma viability and proliferation
14. Neuroblastoma sensitivity to growth inhibition by desferrioxamine. Evidence for a block in G1 phase of the cell cycle
15. The effect of the iron(III) chelator, desferrioxamine, on iron and tranferrin uptake by the human malignant melanoma cell
16. Effect of iron and desferioxamine on cell growth and in vitro ferritin synthesis in human hepatoma cell lines
17. Iron chelators inhibit the growth and induce the apoptosis of Kaposi's sarcoma cells and of their putative endothelial precursors
18. In vitro and in vivo effects of deferoxamine in neonatal acute leukemia
19. Manipulations of cellular iron metabolism for modulating normal and malignant cell proliferation: Achievements and prospects
20. Effects of single course of deferoxamine in neuroblastoma patients
21. Induction of apoptosis by cidofovir in human papillomavirus (HPV)-positive cells
22. Phenotypic instability of drug sensitivity in a human colon carcinoma cell line
23. In vitro sensitivity of Kaposi's sarcoma cells to various chemotherapeutic agents including acyclic nucleoside phosphonates
24. 3H-thymidine pulse-labeling index (TLI) in methanol-fixed human lymphocytes
25. Methotrexate induces apoptotic cell death in human keratinocytes
26. Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma
27. Expression of topoisomerase II and Ki-67 in cervical carcinoma - Clinicopathological study using immunohistochemistry
28. MIB-1 labeling index as a prognostic indicator for survival in patients with FIGO stage IB squamous cell carcinoma of the cervix
29. Expression of proliferating cell nuclear antigen in luminal epithelium during the growth and regression of rat uterus
30. The effect of desferrioxamine on tranferrin receptors, the cell cycle and growth rates of human leukaemic cells
31. Impairment of nucleotide metabolism by iron-chelating deferoxamine
32. Direct evidence that iron deprivation induces apoptosis in murine lymphoma 38C13
33. Release of iron from ferritin molecules and their iron-cores by 3-hydroxypyridinone chelators in vitro
34. Iron chelators induce apoptosis in proliferating cells
35. Survival and desferioxamine in thalassaemia major
36. Studies in desferrioxamine and ferrioxamin metabolism in normal and iron-loaded subjects
37. Pharmacokinetic studies in human with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one